Avalo Therapeutics AVTX
NASDAQ AVTX
$12.26 -0.10 (-0.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Other financing activities (2014 - 2026)

Updated

Avalo Therapeutics' Other financing activities came in at $779,000 for Q1 2026.

Analysis

Avalo Therapeutics (AVTX) Other financing activities (2014 - 2026) Analysis & Trends

For FY2025, Avalo Therapeutics' Other financing activities was $510,000.

  • Other financing activities carries a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Avalo Therapeutics 533.82 Mn -158.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -779,000.00
Dec 31, 2025 -462,000.00
Sep 30, 2025 -1,000.00
Jun 30, 2025 -509,000.00
Dec 31, 2024 -1.73 Mn
Jun 30, 2024 -472,000.00
Mar 31, 2024 -7.01 Mn
Jun 30, 2020 -94,000.00
Dec 31, 2019 -314,021.00
Sep 30, 2019 -204,558.00
Jun 30, 2019 -168,634.00
Mar 31, 2019 -228,678.00
Dec 31, 2018 -157,427.00
Sep 30, 2018 -137,008.00
Dec 31, 2017 3.00
Jun 30, 2017 -88,341.00
Mar 31, 2017 -190,905.00
Dec 31, 2016 -113,478.00
Sep 30, 2016 212,553.00
Jun 30, 2016 -173,052.00
API Access

Avalo Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVTX&period=max&api_key=YOUR_API_KEY